Expression of Regucalcin, a calcium-binding protein is regulated by hypoxia-inducible factor-1α

• DOI: 10.1016/j.lfs.2021.120278
• Publication Date: 2022-01-15T07:33:47Z
• Authors: Tripti Singh; Pallabi Banerjee; Uditi; Sarita Kumari; Anita Chopra; Nagendra Singh; Imteyaz Qamar
• Keywords: Male; 0301 basic medicine; Calcium-Binding Proteins; Intracellular Signaling Peptides and Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Rats; Rats, Sprague-Dawley; 03 medical and health sciences; A549 Cells; Animals; Humans; Hypoxia; Carboxylic Ester Hydrolases

Regucalcin (RGN) regulates intracellular Ca2+ homeostasis and the activity of several proteins involved in intracellular signaling pathways, which highlights its importance in cell biology. Regucalcin has cytoprotective effects reducing intracellular levels of oxidative stress, also playing a crucial role in the control of cell survival and apoptosis. In an effort to assess its gene regulation, we initially identified the expression of Regucalcin in rat lungs treated with hypoxia at various time points. Previously, HIF-1α expression was also reported to be upregulated in hypoxia. Interestingly hypoxic induced Regucalcin expression in a fashion similar to that of HIF-1α expression in rat lungs. Sequence analysis of the Regucalcin promoter region revealed the presence of putative HRE binding motifs. Further analysis of the 1 kb Regucalcin promoter region with 5' deletion and point mutants of HRE binding motif showed that the HRE binding site was critical for high promoter activity. In addition, HIF-1α protein binds directly to the HRE binding motifs within the Regucalcin promoter in-vivo, and regulates Regucalcin gene expression. All together, these findings suggest that Regucalcin is the novel target gene of HIF-1α and that Regucalcin gene expression in hypoxia may be regulated by the control of HIF-1α expression.